Pentylenetetrazol convulsions and brain catecholamine turnover rate in rats and mice receiving diphenylhydantoin or benzodiazepines.
D000818:Animals; D001552:Benzazepines / Q000494:pharmacology*; D001831:Body Temperature / Q000187:drug effects; D001921:Brain / Q000378:metabolism*; D001923:Brain Chemistry / Q000187:drug effects; D002395:Catecholamines / Q000378:metabolism*; D002531:Cerebellum / Q000378:metabolism; D002707:Chlordiazepoxide / Q000494:pharmacology; D003342:Corpus Striatum / Q000378:metabolism; D003975:Diazepam / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism; D007031:Hypothalamus / Q000378:metabolism; D007700:Kinetics; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D051379:Mice; D009638:Norepinephrine / Q000378:metabolism; D010433:Pentylenetetrazole / Q000037:antagonists & inhibitors; D010672:Phenytoin / Q000494:pharmacology*; D051381:Rats; D012640:Seizures / Q000139:chemically induced / Q000378:metabolism*
D001552:Benzazepines; D002395:Catecholamines; D008781:Methyltyrosines; D010672:Phenytoin; D002707:Chlordiazepoxide; D003975:Diazepam; D004298:Dopamine; D010433:Pentylenetetrazole; D009638:Norepinephrine